Aldeyra Therapeutics (ALDX)

Aldeyra Therapeutics (ALDX) Stock Price & Analysis


ALDX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.86 - $10.89
Previous Close$9.34
Average Volume (3M)877.44K
Market Cap
Enterprise Value$563.22M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$16.11M
Price to Earnings (P/E)-9.0
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.04
Shares Outstanding58,576,350
10 Day Avg. Volume669,432
30 Day Avg. Volume877,444
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-11.72
Price Target Upside115.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Aldeyra Therapeutics’s price range in the past 12 months?
Aldeyra Therapeutics lowest stock price was $2.86 and its highest was $10.88 in the past 12 months.
    What is Aldeyra Therapeutics’s market cap?
    Currently, no data Available
    When is Aldeyra Therapeutics’s upcoming earnings report date?
    Aldeyra Therapeutics’s upcoming earnings report date is Aug 10, 2023 which is in 71 days.
      How were Aldeyra Therapeutics’s earnings last quarter?
      Aldeyra Therapeutics released its earnings results on May 04, 2023. The company reported -$0.27 earnings per share for the quarter, beating the consensus estimate of -$0.29 by $0.02.
        Is Aldeyra Therapeutics overvalued?
        According to Wall Street analysts Aldeyra Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Aldeyra Therapeutics pay dividends?
          Aldeyra Therapeutics does not currently pay dividends.
          What is Aldeyra Therapeutics’s EPS estimate?
          Aldeyra Therapeutics’s EPS estimate is -$0.31.
            How many shares outstanding does Aldeyra Therapeutics have?
            Aldeyra Therapeutics has 58,576,350 shares outstanding.
              What happened to Aldeyra Therapeutics’s price movement after its last earnings report?
              Aldeyra Therapeutics reported an EPS of -$0.27 in its last earnings report, beating expectations of -$0.29. Following the earnings report the stock price went up 2.063%.
                Which hedge fund is a major shareholder of Aldeyra Therapeutics?
                Among the largest hedge funds holding Aldeyra Therapeutics’s share is Perceptive Advisors LLC. It holds Aldeyra Therapeutics’s shares valued at 113M.


                  Aldeyra Therapeutics Stock Smart Score

                  The Aldeyra Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Aldeyra Therapeutics

                  Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.


                  Top 5 ETFs holding ALDX

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  Dimensional U.S. Equity ETF
                  Up to five ETFs with an Outperform Smart Score that hold ALDX. The ETFs are listed according to market value of ALDX within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Kinnate Biopharma
                  Omega Therapeutics
                  Aadi Bioscience

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis